HealthDay.com
Visual Impairment Expected to Rise Significantly by 2050
Aging boomers will trigger a doubling of blind or visually impaired people in next three decades
High Rate of Cerebral Embolization During TAVR
No significant differences in cerebral embolization measures during TAVR with bivalirudin vs. heparin
Major Stroke May Be Prevented by Taking Aspirin After TIA
Researchers find risk is reduced by as much as 80 percent
Lifestyle Intervention Before Infertility Treatment No Benefit
Lifestyle intervention preceding infertility treatment doesn't up vaginal birth rates in obese women
Danazol Treatment Linked to Telomere Elongation
Reduction in rate of telomere attrition at 24 months; gain in telomere length seen from six months
![Treatment with sulfonylureas (ATP-sensitive potassium [KATP] channel blockers) may inhibit the neuroprotective effects of KATP channel activation and increase the risk of stroke](https://www.ehealth-news.com/wp-content/uploads/2016/05/18120-1.jpeg "Sulfonylureas May Inhibit KATP Channel Neuroprotection")
Sulfonylureas May Inhibit KATP Channel Neuroprotection
Treatment with sulfonylureas may increase the risk of stroke mortality in patients with type 2 diabetes
Early Loss of Islet Sympathetic Nerves in Type 1 Diabetes
Early, marked, and sustained loss of islet sympathetic nerves in type 1 but not type 2 diabetes
FDA Approves Tecentriq to Treat Urothelial Carcinoma
FDA also approves a companion test to detect PD-L1 protein expression levels in patients
ASCO: Pembrolizumab Improves Survival in Melanoma
Three-year overall survival rate of 40 percent; median overall survival of 24.4 months
American Psychiatric Association, May 14-18
The 168th American Psychiatric Association Annual Meeting The annual meeting of the American Psychiatric Association was held from May 14 to 18 in...
